Vous êtes ici

BioVaxys Technology Corp.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
BIOV
Indice CSE: 
CSE Composite
Devise: 
CAD

BioVaxys Technology Corp. is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on its DPX™ immune-educating technology platform and its HapTenix© tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization for food allergy, and other immunological diseases. Through a differentiated mechanism of action, the DPX™ platform delivers instruction to the immune system to generate a specific, robust, and persistent immune response. The Company's clinical stage pipeline includes maveropepimut-S (MVP-S), based on the DPX™ platform, and is in Phase IIB clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant Ovarian Cancer. MVP-S delivers antigenic peptides from survivin, a well-recognized cancer antigen commonly overexpressed in advanced cancers, and also delivers an innate immune activator and a universal CD4 T cell helper peptide. MVP-S has been well tolerated and has demonstrated defined clinical benefit in multiple cancer indications as well as the activation of a targeted and sustained, survivin-specific anti-tumor immune response. BioVaxys is also developing DPX™+SurMAGE, a dual-targeted immunotherapy combining antigenic peptides for both the survivin and MAGE-A9 cancer proteins to elicit immune responses to these two distinct cancer antigens simultaneously, DPX™-RSV for Respiratory Syncytial Virus, DPX+rPA for peanut allergy prophylaxis, and BVX-0918, a personalized immunotherapeutic vaccine using its proprietary HapTenix© 'neoantigen' tumor cell construct platform for refractive late-stage ovarian cancer. 

BioVaxys Technology Corp. (BIOV)

0.05
0.00 (0.00%)

BioVaxys Technology Corp. (BIOV)

*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.

Citation

Quantité demandé
211,000 
Cours acheteur
0.045 
Cours vendeur
0.05 
Quantité offerte
16,000 
Volume
5,000 
Dernier prix
0.05 
Écart minimum
Up 
variation nette
 
Clôture précédente
0.05 
Ouverture
0.05 
Day High
0.05 
Day Low
0.05 
Haut 52 semaines
0.09 
Bas 52 semaines
0.04 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Quantité demandé
20,000 
Cours acheteur
0.04 
Cours vendeur
0.00 
Quantité offerte
Volume
Dernier prix
0.045 
Écart minimum
Up 
variation nette
 
Clôture précédente
0.045 
Ouverture
0.00 
Day High
0.00 
Day Low
0.00 
Haut 52 semaines
 
Bas 52 semaines
 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Citation

Quantité demandé
211,000 
Cours acheteur
0.045 
Cours vendeur
0.05 
Quantité offerte
16,000 
Volume
5,000 
Dernier prix
0.05 
Écart minimum
Up 
variation nette
 
Clôture précédente
0.05 
Ouverture
0.05 
Day High
0.05 
Day Low
0.05 
Haut 52 semaines
0.09 
Bas 52 semaines
0.04 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Quantité demandé
20,000 
Cours acheteur
0.04 
Cours vendeur
0.00 
Quantité offerte
Volume
Dernier prix
0.045 
Écart minimum
Up 
variation nette
 
Clôture précédente
0.045 
Ouverture
0.00 
Day High
0.00 
Day Low
0.00 
Haut 52 semaines
 
Bas 52 semaines
 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Profondeur de marche par ordre

  • BIOV / Dernière mise à jour: 15:25:20 ET
  • Refresh
  • Info
Courtier Bid Quantité demandé Cours acheteur Cours vendeur Quantité offerte Demandez Broker
CIBC World Markets Inc. 50,000 0.045 0.05 11,000 TD Securities Inc.
W.D. Latimer Co. Limited 10,000 0.045 0.05 2,000 National Bank Financial Inc.
National Bank Financial Inc. 4,000 0.045 0.05 3,000 TD Securities Inc.
TD Securities Inc. 20,000 0.045 0.055 21,000 CIBC World Markets Inc.
TD Securities Inc. 1,000 0.045 0.055 127,000 RBC Capital Markets
Questrade Inc. 10,000 0.045 0.055 30,000 Questrade Inc.
National Bank Financial Inc. 11,000 0.045 0.055 25,000 BMO Nesbitt Burns Inc.
Anonymous 5,000 0.045 0.055 35,000 BMO Nesbitt Burns Inc.
Scotia Capital Inc. 9,000 0.045 0.055 40,000 BMO Nesbitt Burns Inc.
BMO Nesbitt Burns Inc. 15,000 0.045 0.055 10,000 National Bank Financial Inc.
Courtier Bid Quantité demandé Cours acheteur Cours vendeur Quantité offerte Demandez Broker
Anonymous 20,000 0.04 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0

Profondeur d'affichage de prix

  • BIOV / Dernière mise à jour: 15:25:20 ET
  • Refresh
  • Info
Acheteur Quantité demandé Cours acheteur Cours vendeur Quantité offerte Vendeur
13 211,000 0.045 0.05 16,000 3
14 431,000 0.04 0.055 291,000 9
7 183,000 0.035 0.06 42,000 6
5 183,000 0.03 0.065 114,000 16
4 129,000 0.025 0.07 83,000 7
Acheteur Quantité demandé Cours acheteur Cours vendeur Quantité offerte Vendeur
1 20,000 0.04 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0

Métiers récents

  • BIOV / Dernière mise à jour: 11:33:03 ET
  • Refresh
  • Info
Date/Heure Prix Modifier Volume Acheteur Vendeur Venue
Apr 2, 15:33 0.05 0.00 1,000 Anonymous Desjardins Securities Inc. CSE
Apr 2, 15:33 0.05 0.00 4,000 National Bank Financial Inc. Desjardins Securities Inc. CSE
Apr 1, 19:33 0.05 0.00 1,000 Anonymous TD Securities Inc. CSE
Apr 1, 19:33 0.05 0.00 2,000 Anonymous TD Securities Inc. CSE
Apr 1, 19:19 0.05 0.00 1,000 National Bank Financial Inc. TD Securities Inc. CSE

Information d'entreprise

Addresse
146 Thirtieth Street
Suite 100
Etobicoke, ON M8W 3C4
Canada
Téléphone
646-452-7000
Courriel
jpassin@biovaxys.com
URL
https://biovaxys.com/
Date d’inscription à la cote
Mercredi, novembre 21, 2018
Agent de transfert
Odyssey Trust Company
Courriel
news@biovaxys.com
Vérificateur
Dale Matheson Carr-Hilton Labonte LLP

SEDAR Information

Type de dossier Tout News Releases Material Change Report Management's Discussion & Analysis Financial Statements
Délai @count semaine@count mois3 month6 month@count annéeTout le temps

Information d'entreprise

Addresse
146 Thirtieth Street
Suite 100
Etobicoke, ON M8W 3C4
Canada
Téléphone
646-452-7000
Courriel
jpassin@biovaxys.com
URL
https://biovaxys.com/
Date d’inscription à la cote
Mercredi, novembre 21, 2018
Agent de transfert
Odyssey Trust Company
Courriel
news@biovaxys.com
Vérificateur
Dale Matheson Carr-Hilton Labonte LLP

Capitalisation

Capitalisation: 
291525203
Réservé à l'émission: 
139701394

Company Officers

James Passin, CEO
Kenneth Kovan, COO & President
Christopher Cherry, Chief Financial Officer
James Passin, Chief Executive Officer
Christopher Cherry, Chief Financial Officer
Kenneth Kovan, Chief Operating Officer and President